Skip to main content
Log in

Interactions Between Antiepileptic Drugs and Hormonal Contraception

  • Review Article
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

An interaction between antiepileptic drugs (AEDs) and the combined oral contraceptive pill was first proposed when the dose of estradiol in the oral contraceptive pill was reduced from 100 to 50μg. There was a higher incidence of breakthrough bleeding and contraceptive failure among women with epilepsy compared with women in general.

Since then, interaction studies have been undertaken to look for possible interactions between AEDs and the combined oral contraceptive pill. Phenobarbital (phenobarbitone), phenytoin, carbamazepine, oxcarbazepine, felbamate and topiramate have been shown to increase the metabolism of ethinylestradiol and progestogens. Therefore, if a women is on one of the AEDs and wishes to take the oral contraceptive pill, she will need to take a preparation containing at least 50μg of ethinylestradiol. Levonorgestrel implants are contraindicated in women receiving these AEDs because of cases of contraceptive failure. It is recommended that medroxyprogesterone injections be given every 10 rather than 12 weeks to women who are receiving AEDs that induce hepatic microsomal enzymes.

There are no interactions between the combined oral contraceptive pill, progesterone-only pill, medroxyprogesterone injections or levonorgestrel implants and the AEDs valproic acid (sodium valproate), vigabatrin, lamotrigine, gabapentin, tiagabine, levetiracetam, zonisamide, ethosuximide and the benzodiazepines. Therefore, normal dose contraceptive preparations can be used in patients receiving these AEDs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

Notes

  1. Use of tradenames is for product identification only and does not imply endorsement.

References

  1. Kenyon TE. Unplanned pregnancy in an epileptic. BMJ 1972; 1: 686–7

    Article  PubMed  CAS  Google Scholar 

  2. Coulam CB, Annegers JF. Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 1979; 20: 519–26

    Article  PubMed  CAS  Google Scholar 

  3. Back DJ, Grimmer SFM, Orme ML, et al. Evaluation of Committee on Safety of Medicine yellow card reports on oral contraceptive interactions. Br J Pharmacokinet Pharmacol 1988; 13: 527–32

    Google Scholar 

  4. Park BK, Breckenridge AM. Clinical implications of enzyme induction and enzyme inhibition. Clin Pharmacokinet 1981; 6: 1–24

    Article  PubMed  CAS  Google Scholar 

  5. Backström T, Sodergärd R. The influence of antiepileptic drugs on steroid plasma levels and binding during the menstrual cycle [abstract]. Acta Endocrinol Suppl (Copenh) 1977; Suppl. 212: 42

    Google Scholar 

  6. Perucca E, Hedges A, Makki KA, et al. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in antiepileptic patients. Br J Pharmacol 1984; 11: 533–9

    Google Scholar 

  7. Tomson T, Svensson J, Hilton-Brown P. Relationship of inter-individual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism. Ther Drug Monit 1989; 11:533–9

    Article  PubMed  CAS  Google Scholar 

  8. Bertz RJ, Granneman GR. Use of in vitro and in vivo data to estimate likelihood of metabolic pharmacodynamic interactions. Clin Pharmacokinet 1997; 32: 210–58

    Article  PubMed  CAS  Google Scholar 

  9. Wright SA, Stevens JC. The human hepatic cytochromes 450 involved in drug metabolism. Crit Rev Toxicol 1992; 22: 1–21

    Article  Google Scholar 

  10. Levy RH. Cytochrome P450 isoenzymes and anti epileptic drug interactions. Epilepsia 1995; 36Suppl. 5: S8–13

    Article  PubMed  Google Scholar 

  11. D’Arcy PF. Drug interactions with oral contraceptives. Drug Intell Clin Pharm 1986; 20: 353–62

    PubMed  Google Scholar 

  12. Back DJ, Orme MLE. Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet 1990; 18: 472–84

    Article  PubMed  CAS  Google Scholar 

  13. Wilkinson GR. Clearance approaches in pharmacology. Pharmacol Rev 1987; 39: 1–47

    PubMed  CAS  Google Scholar 

  14. Back DJ, Bates M, Bowden A, et al. The interactions of phenobarbital and other anticonvulsants with oral contraceptive therapy. Contraception 1980; 22: 495–503

    Article  PubMed  CAS  Google Scholar 

  15. Sonnen AEH. Sodium valproate and the pill. In: Akimoto H, Kazamatsun H, Seino M, et al., editors. Advances in epileptology. Proceedings of the 13th Epilepsy International Symposium. New York: Raven Press, 1982: 429–32

    Google Scholar 

  16. Crawford P, Chadwick DJ, Martin C, et al. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids. Br J Clin Pharmacol 1990; 30: 892–6

    Article  PubMed  CAS  Google Scholar 

  17. Crawford PM, Chadwick D, Cleland P, et al. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptives. Contraception 1986; 33: 23–9

    Article  PubMed  CAS  Google Scholar 

  18. Bartoli A, Gatti G, Cipolla G, et al. A double-blind placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers. Epilepsia 1997; 36: 702–7

    Article  Google Scholar 

  19. Saano V, Banield CR, Reidenberg P, et al. Effects of felbamate on the pharmacokinetics of low-dose combination oral contraceptive. Clin Pharmacol Ther 1995; 58: 523–31

    Article  PubMed  CAS  Google Scholar 

  20. Holdich T, Whiteman P, Orme M, et al. Effect of lamotrigine on the pharmacology of the combined oral contraceptive pill. Epilepsia 1991; 32Suppl. 1: 96

    Google Scholar 

  21. Eldon MA, Underwood BA, Randinitis EJ, et al. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol. Neurology 1998; 50: 1146–8

    Article  PubMed  CAS  Google Scholar 

  22. Rosenfeld WE, Doose DR, Walker SA, et al. Effects of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia 1997; 38: 317–23

    Article  PubMed  CAS  Google Scholar 

  23. Mengel HB, Houston A, Back DJ. An evaluation of the interaction between tiagabine and oral contraceptives in female volunteers. J Pharm Med 1994; 4: 141–50

    Google Scholar 

  24. Klosterkov JP, Saano V, Haring P, et al. Possible interaction between oxcarbazepine and an oral contraceptive. Epilepsia 1992; 33: 1149–52

    Article  Google Scholar 

  25. Fattore C, Cipolla G, Gatti G, et al. Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women. Epilepsia 1999; 40: 783–7

    Article  PubMed  CAS  Google Scholar 

  26. Giuliano RA, Hiersemenzel E, Baltes G, et al. Influence of a new antiepileptic drug (Levetiracetam, ucbLO59) on the pharmacokinetics and pharmacodynamics of oral contraceptives [abstract]. Epilepsia 1996; 37Suppl. 4: 90

    Google Scholar 

  27. Orme M, Crawford P, Chadwick D, et al. af]Contraception, epilepsy and pharmacokinetics. In: Trimble MR, editor. Women and epilepsy. Chichester: J. Wiley & Sons, 1991: 145–58

    Google Scholar 

  28. Geurts TBP, Goorissen EM, Sitsen JME. Summary of drug interactions with oral contraceptives. Carnforth, Lancs: Parthenon Publishing Group, 1993: 57

    Google Scholar 

  29. Gilbert JC, Scott AC, Galloway DB, et al. Ethosuximide liver enzyme induction and D-glucaric acid excretion. Br J Clin Pharmacol 1974; 1: 249–52

    Article  PubMed  CAS  Google Scholar 

  30. Kurt H. Interactions between anticonvulsants and other commonly prescribed drugs. Epilepsia 1984; 25: S118–31

    Article  Google Scholar 

  31. Frisium. ABPI: Compendium of data sheets. Summary of product characteristics. 1999–2000. London: Datapharm Publications Ltd., 1999: 568–9

    Google Scholar 

  32. Mehta DK, editor. British National Formulary — BNF40, September 2000. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2000

    Google Scholar 

  33. Schumacher RC, Fantel C, Kelton E, et al. Evaluation of elimination of 14C-felbamate in healthy men [abstract]. Epilepsia 1990; 31Suppl. 1: 21–2

    Google Scholar 

  34. Wilbur K, Ensom MHH. Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants. Clin Pharmacokinet 2000; 38: 355–65

    Article  PubMed  CAS  Google Scholar 

  35. Levy RH, Bishop F, Streeter AJ, et al. Explanation and prediction of drug interactions with topiramate using CYP450 inhibition spectrum. Epilepsia 1995; 36Suppl. 4: 47–51

    Google Scholar 

  36. Nicolas JM, Collart P, Gerin B, et al. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent. Drug Metab Dispos 1999; 27: 250–4

    PubMed  CAS  Google Scholar 

  37. Nakasa H, Komiya M, Ohmori S, et al. Characterisation of human liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide. Drug Metab Dispos 1993; 21: 777–81

    PubMed  CAS  Google Scholar 

  38. Nakasa H, Nakamura H, Ono S, et al. Prediction of drug-drug interactions of zonisamide in humans from in vitro data. Eur J Clin Pharmacol 1998; 52(2): 177–83

    Article  Google Scholar 

  39. Betts T, Crawford P. Women and epilepsy. London: Martin Dunitz, 1998

    Google Scholar 

  40. Krauss GL, Brandt J, Campbell M, et al. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians. Neurology 1996; 46: 1534–9

    Article  PubMed  CAS  Google Scholar 

  41. Haukkamaa M. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant therapy. Contraception 1986; 33: 559–65

    Article  PubMed  CAS  Google Scholar 

  42. Crawford P, Lee P. Gender difference in the management of epilepsy — what women are hearing. Seizure 1999; 8: 135–9

    Article  PubMed  CAS  Google Scholar 

  43. Trussell J, Kost K. Aguide to interpreting contraceptive efficacy studies. Obstet Gynacol 1990; 76: 558–67

    CAS  Google Scholar 

Download references

Acknowledgements

No funding was used in the preparation of this manuscript. The author has undertaken studies for and had sponsorship from GlaxoSmithKline, JanssenCilag, Novartis, Sanofi-Synthelabo, UCB, Parke-Davis and Elan Pharmaceuticals.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pamela Crawford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crawford, P. Interactions Between Antiepileptic Drugs and Hormonal Contraception. Mol Diag Ther 16, 263–272 (2002). https://doi.org/10.2165/00023210-200216040-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-200216040-00005

Keywords

Navigation